Analysis of patients with two hereditary cancers (breast/ovarian or colon/endometrial) who met NCCN genetic testing criteria after their first cancer.

被引:0
|
作者
Saam, Jennifer [1 ]
Moyes, Kelsey [1 ]
Arnell, Christopher [1 ]
Landon, Michelle [1 ]
Kaldate, Rajesh R. [1 ]
Strike, Brian [1 ]
Williams, Kayon [1 ]
Burbidga, Lynn Anna [1 ]
Abbott, Brian [1 ]
机构
[1] Myriad Genet Labs Inc, Salt Lake City, UT USA
关键词
D O I
10.1200/jco.2014.32.15_suppl.1542
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1542
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Comparing family members’ motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis
    Caroline Dancyger
    Jonathan A Smith
    Chris Jacobs
    Melissa Wallace
    Susan Michie
    European Journal of Human Genetics, 2010, 18 : 1289 - 1295
  • [42] Genetic testing at the time of diagnosis Women's experiences when offered genetic testing immediately after receiving a diagnosis of breast- or ovarian cancer.
    Augestad, Mirjam Tonheim
    Hoberg-Vetti, Hildegunn
    Bjorvatn, Cathrine
    Sekse, Ragnhild Johanne Tveit
    PSYCHO-ONCOLOGY, 2016, 25 (SP. S3) : 62 - 63
  • [43] Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario
    Vidal, Ricardo dos Santos
    Hawrysh, Andrea
    Walia, Jagdeep S.
    Davey, Scott
    Feilotter, Harriet
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (03): : 362 - 369
  • [44] Hereditary Nonpolyposis Colon Cancer: Revised Bethesda Criteria, Immunohistochemistry, Microsatellite Instability, Germline Analysis, and Emerging Issues in Genetic Testing
    Doxey, Brett W.
    Kuwada, Scott K.
    CURRENT COLORECTAL CANCER REPORTS, 2007, 3 (01) : 10 - 15
  • [45] Maximising survival: The main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2
    Jeffers, Lisa
    Morrison, Patrick J.
    McCaughan, Eilis
    Fitzsimons, Donna
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2014, 18 (04) : 411 - 418
  • [46] Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
    Arai, Masami
    Yokoyama, Shiro
    Watanabe, Chie
    Yoshida, Reiko
    Kita, Mizuho
    Okawa, Megumi
    Sakurai, Akihiro
    Sekine, Masayuki
    Yotsumoto, Junko
    Nomura, Hiroyuki
    Akama, Yoshinori
    Inuzuka, Mayuko
    Nomizu, Tadashi
    Enomoto, Takayuki
    Nakamura, Seigo
    JOURNAL OF HUMAN GENETICS, 2018, 63 (04) : 447 - 457
  • [47] Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
    Masami Arai
    Shiro Yokoyama
    Chie Watanabe
    Reiko Yoshida
    Mizuho Kita
    Megumi Okawa
    Akihiro Sakurai
    Masayuki Sekine
    Junko Yotsumoto
    Hiroyuki Nomura
    Yoshinori Akama
    Mayuko Inuzuka
    Tadashi Nomizu
    Takayuki Enomoto
    Seigo Nakamura
    Journal of Human Genetics, 2018, 63 : 447 - 457
  • [48] A retrospective study on surveillance behavior and prophylaxis after genetic testing for hereditary breast and ovarian cancer in Hong Kong Chinese families.
    Kwong, A.
    Chu, A. T.
    Wu, C. T.
    Wong, C. H.
    Tsui, E. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history
    Ava Kwong
    Annie Tsz-Wai Chu
    Christine Teen-Sum Wu
    Desiree Man-Sik Tse
    Familial Cancer, 2014, 13 : 423 - 430
  • [50] Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history
    Kwong, Ava
    Chu, Annie Tsz-Wai
    Wu, Christine Teen-Sum
    Tse, Desiree Man-Sik
    FAMILIAL CANCER, 2014, 13 (03) : 423 - 430